BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31185949)

  • 1. Cancer stigma and cancer screening attendance: a population based survey in England.
    Vrinten C; Gallagher A; Waller J; Marlow LAV
    BMC Cancer; 2019 Jun; 19(1):566. PubMed ID: 31185949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer worries and uptake of breast, cervical, and colorectal cancer screening: A population-based survey in England.
    Quaife SL; Waller J; von Wagner C; Vrinten C
    J Med Screen; 2019 Mar; 26(1):3-10. PubMed ID: 30249158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative exploration of cervical and breast cancer stigma in Karnataka, India.
    Nyblade L; Stockton M; Travasso S; Krishnan S
    BMC Womens Health; 2017 Aug; 17(1):58. PubMed ID: 28768506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional survey assessing factors associated with reading cancer screening information: previous screening behaviour, demographics and decision-making style.
    Ghanouni A; Renzi C; Waller J
    BMC Public Health; 2017 Apr; 17(1):327. PubMed ID: 28420378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why colorectal screening fails to achieve the uptake rates of breast and cervical cancer screening: a comparative qualitative study.
    Kotzur M; McCowan C; Macdonald S; Wyke S; Gatting L; Campbell C; Weller D; Crighton E; Steele RJC; Robb KA
    BMJ Qual Saf; 2020 Jun; 29(6):482-490. PubMed ID: 31879320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does lung cancer attract greater stigma than other cancer types?
    Marlow LA; Waller J; Wardle J
    Lung Cancer; 2015 Apr; 88(1):104-7. PubMed ID: 25704958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonadherence to breast and cervical cancer screening among sexual minority women: Do stigma-related psychological barriers play a role?
    Milner GE; McNally RJ
    Health Psychol; 2020 Oct; 39(10):891-899. PubMed ID: 32686952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of multimorbidity with breast, cervical, and colorectal cancer screening delivery: a cross-sectional study of a nationally representative Japanese sample.
    Yamashita H; Takahashi Y; Ishizaki T; Imura H; Nakayama T
    Cancer Epidemiol; 2020 Dec; 69():101798. PubMed ID: 32980753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of gender in perspectives of discrimination, stigma, and attitudes relative to cervical cancer in rural Sénégal.
    Ongtengco N; Thiam H; Collins Z; De Jesus EL; Peterson CE; Wang T; Hendrix E; Ndiaye Y; Gueye B; Gassama O; Kasse AA; Faye A; Smith JS; Fitzgibbon M; Dykens JA
    PLoS One; 2020; 15(4):e0232291. PubMed ID: 32343755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of receiving lifestyle advice at cervical, breast and bowel cancer screening.
    Stevens C; Vrinten C; Smith SG; Waller J; Beeken RJ
    Prev Med; 2019 Mar; 120():19-25. PubMed ID: 30578909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in depression stigma towards ethnic and socio-economic groups in Germany - Exploring the hypothesis of double stigma.
    Knesebeck OVD; Kofahl C; Makowski AC
    J Affect Disord; 2017 Jan; 208():82-86. PubMed ID: 27750064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive symptoms, neuroticism, and participation in breast and cervical cancer screening: Cross-sectional and prospective evidence from UK Biobank.
    Niedzwiedz CL; Robb KA; Katikireddi SV; Pell JP; Smith DJ
    Psychooncology; 2020 Feb; 29(2):381-388. PubMed ID: 31663185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in cervical and breast cancer screening coverage in England: a cross-sectional analysis to characterise districts with atypical behaviour.
    Massat NJ; Douglas E; Waller J; Wardle J; Duffy SW
    BMJ Open; 2015 Jul; 5(7):e007735. PubMed ID: 26209119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a scale to assess cancer stigma in the non-patient population.
    Marlow LA; Wardle J
    BMC Cancer; 2014 Apr; 14():285. PubMed ID: 24758482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Evaluation of Cancer Stigma among Non-Patient Population in Oman.
    Al Naabi M; Al Zaabi A
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1223-1229. PubMed ID: 38679981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lack of information engagement among colorectal cancer screening non-attenders: cross-sectional survey.
    Kobayashi LC; Waller J; von Wagner C; Wardle J
    BMC Public Health; 2016 Jul; 16():659. PubMed ID: 27473593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a pilot study for breast and cervical cancer screening with Bradford's minority ethnic women; a community development approach, 1991-93.
    Kernohan EE
    Br J Cancer Suppl; 1996 Sep; 29():S42-6. PubMed ID: 8782798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between cancer stigma and cervical cancer screening uptake among women of Dhulikhel and Banepa, Nepal.
    Paneru B; Karmacharya A; Bharati A; Makaju S; Adhikari B; Kafle D; Shakya S; Spiegelman D; Seth S; Stangl A; Shrestha AD; Shrestha A
    PLoS One; 2023; 18(5):e0285771. PubMed ID: 37200234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public understanding of the purpose of cancer screening: A population-based survey.
    Chorley AJ; Hirst Y; Vrinten C; von Wagner C; Wardle J; Waller J
    J Med Screen; 2018 Jun; 25(2):64-69. PubMed ID: 28530514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast and bowel cancer screening uptake patterns over 15 years for UK south Asian ethnic minority populations, corrected for differences in socio-demographic characteristics.
    Szczepura A; Price C; Gumber A
    BMC Public Health; 2008 Oct; 8():346. PubMed ID: 18831751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.